Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Angiodynamics (ANGO) over the last 16 years, with Q4 2025 value amounting to $3.3 million.

  • Angiodynamics' Change in Inventory rose 16248.0% to $3.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$483000.0, marking a year-over-year decrease of 10822.97%. This contributed to the annual value of $1.3 million for FY2025, which is 8568.54% down from last year.
  • Latest data reveals that Angiodynamics reported Change in Inventory of $3.3 million as of Q4 2025, which was up 16248.0% from $192000.0 recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Change in Inventory peaked at $6.2 million during Q3 2022, and registered a low of -$4.1 million during Q2 2023.
  • Moreover, its 5-year median value for Change in Inventory was $546500.0 (2021), whereas its average is $1.2 million.
  • In the last 5 years, Angiodynamics' Change in Inventory skyrocketed by 90571.43% in 2022 and then plummeted by 57730.5% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Change in Inventory stood at -$1.1 million in 2021, then surged by 587.2% to $5.6 million in 2022, then dropped by 23.65% to $4.3 million in 2023, then tumbled by 70.73% to $1.2 million in 2024, then surged by 162.48% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q4 2025, $192000.0 for Q3 2025, and -$1.1 million during Q2 2025.